Blue Earth Diagnostics Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 108

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $466M

Blue Earth Diagnostics General Information

Description

Developer of molecular imaging agents designed to address unmet clinical needs and reliably inform diagnosis decisions. The company imaging agents can be used for PET imaging to detect and localize prostate cancer in men with the diagnosis of biochemical recurrence as well as in amino acid transport and radiopharmaceutical therapies, enabling medical practitioners to diagnose and treat brain and prostate cancer patients with improved efficiency.

Contact Information

Website
www.blueearthdiagnostics.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • The Oxford Science Park
  • Magdalen Centre, Robert Robinson Avenue
  • Oxford OX4 4GA
  • England, United Kingdom
+44 01865
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
Blue Earth Therapeutics
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • The Oxford Science Park
  • Magdalen Centre, Robert Robinson Avenue
  • Oxford OX4 4GA
  • England, United Kingdom
+44 01865

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Blue Earth Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 01-Aug-2019 $466M Completed Profitable
2. Grant 01-Apr-2015 Completed Startup
1. Early Stage VC 11-Mar-2014 $21.3M $21.3M Completed Startup
To view Blue Earth Diagnostics’s complete valuation and funding history, request access »

Blue Earth Diagnostics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of molecular imaging agents designed to address unmet clinical needs and reliably inform diagnosis decisions.
Drug Discovery
Oxford, United Kingdom
108 As of 2025

Inglewood, CA
 

Houston, TX
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Blue Earth Diagnostics Competitors (12)

One of Blue Earth Diagnostics’s 12 competitors is ImaginAb, a Venture Capital-Backed company based in Inglewood, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ImaginAb Venture Capital-Backed Inglewood, CA
RadioMedix Venture Capital-Backed Houston, TX
QUE Oncology Venture Capital-Backed Atlanta, GA
Telix Pharmaceuticals Formerly VC-backed North Melbourne, Australia
Navidea Biopharmaceuticals Corporation Dublin, OH
You’re viewing 5 of 12 competitors. Get the full list »

Blue Earth Diagnostics Patents

  • 41

    Total Documents Applications and Grants

  • Total Patents Families

  • 19

    Granted

  • 12

    Pending

  • Expiring in next 12 mo

Blue Earth Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202316239-D0 Therapeutic combination Pending 24-Oct-2023
GB-202207372-D0 Synthesis of fluorosilyl compounds Inactive 19-May-2022
US-20230218255-A1 Imaging of myeloma bone lesions Inactive 07-Jan-2022
EP-4460337-A1 Imaging of myeloma bone lesions Pending 07-Jan-2022
AU-2023205459-A1 Imaging of myeloma bone lesions Pending 07-Jan-2022 A61K51/0406
To view Blue Earth Diagnostics’s complete patent history, request access »

Blue Earth Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Blue Earth Diagnostics Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovate UK Government
Syncona Venture Capital Minority
To view Blue Earth Diagnostics’s complete investors history, request access »

Ready to get started?

Request a free trial

Blue Earth Diagnostics FAQs

  • When was Blue Earth Diagnostics founded?

    Blue Earth Diagnostics was founded in 2013.

  • Where is Blue Earth Diagnostics headquartered?

    Blue Earth Diagnostics is headquartered in Oxford, United Kingdom.

  • What is the size of Blue Earth Diagnostics?

    Blue Earth Diagnostics has 108 total employees.

  • What industry is Blue Earth Diagnostics in?

    Blue Earth Diagnostics’s primary industry is Drug Discovery.

  • Is Blue Earth Diagnostics a private or public company?

    Blue Earth Diagnostics is a Private company.

  • What is the current valuation of Blue Earth Diagnostics?

    The current valuation of Blue Earth Diagnostics is .

  • What is Blue Earth Diagnostics’s current revenue?

    The current revenue for Blue Earth Diagnostics is .

  • How much funding has Blue Earth Diagnostics raised over time?

    Blue Earth Diagnostics has raised $21.3M.

  • Who are Blue Earth Diagnostics’s investors?

    Innovate UK and Syncona have invested in Blue Earth Diagnostics.

  • Who are Blue Earth Diagnostics’s competitors?

    ImaginAb, RadioMedix, QUE Oncology, Telix Pharmaceuticals, and Navidea Biopharmaceuticals are some of the 12 competitors of Blue Earth Diagnostics.

  • When was Blue Earth Diagnostics acquired?

    Blue Earth Diagnostics was acquired on 01-Aug-2019.

  • Who acquired Blue Earth Diagnostics?

    Blue Earth Diagnostics was acquired by Blue Earth Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »